{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:51:43Z","timestamp":1791409903487,"version":"4.3.3"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,8,8]],"date-time":"2027-08-08T00:00:00Z","timestamp":1817683200000},"content-version":"am","delay-in-days":311,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH2210283"],"award-info":[{"award-number":["W81XWH2210283"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-16-1-0691"],"award-info":[{"award-number":["W81XWH-16-1-0691"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01AI158569\\u201301"],"award-info":[{"award-number":["1R01AI158569\\u201301"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012220","name":"Hercules Foundation","doi-asserted-by":"publisher","award":["20100225\\u20137"],"award-info":[{"award-number":["20100225\\u20137"]}],"id":[{"id":"10.13039\/100012220","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioorg.2026.110337","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T06:32:59Z","timestamp":1786084379000},"page":"110337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Synthesis and evaluation of 3,5-disubstituted isothiazolo[4,5-b]pyridines, pyrazolo[4,3-b]pyridines and isothiazolo[3,4-b]pyrazines as inhibitors of PIKfyve"],"prefix":"10.1016","volume":"181","author":[{"given":"Ling-Jie","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathy","family":"Froeyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Wen","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do Hoang Nhu","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Van Loy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Schols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jef","family":"Rozenski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim","family":"Dehaen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirit","family":"Einav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"De Jonghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.110337_bb0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ceb.2019.12.007","article-title":"Novel roles of Phosphoinositides in Signaling, lipid transport, and disease","volume":"63","author":"Hammond","year":"2020","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.bioorg.2026.110337_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2022.102086","article-title":"Roles of PIKfyve in multiple cellular pathways","volume":"76","author":"Rivero-R\u00edos","year":"2022","journal-title":"Curr. Opin. Cell Biol."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110337_bb0015","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/01.ibd.0000225337.14356.31","article-title":"A phase 1\/2A trial of STA 5326, an Oral Interleukin-12\/23 inhibitor, in patients with active moderate to severe Crohn\u2019s disease","volume":"12","author":"Burakoff","year":"2006","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bioorg.2026.110337_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2026.178909","article-title":"Apilimod in oncology: from non-malignant origins to emerging anti-Cancer potential","volume":"1025","author":"Evrard","year":"2026","journal-title":"Eur. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.bioorg.2026.110337_bb0025","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1182\/blood-2016-09-736892","article-title":"Identification of Apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma","volume":"129","author":"Gayle","year":"2017","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110337_bb0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005540","article-title":"The Phosphatidylinositol-3-phosphate 5-kinase inhibitor Apilimod blocks filoviral entry and infection","volume":"11","author":"Nelson","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bioorg.2026.110337_bb0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.virol.2022.05.004","article-title":"Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, Delta and Omicron variant infection","volume":"572","author":"Kumar","year":"2022","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110337_bb0040","doi-asserted-by":"crossref","DOI":"10.1128\/aac.01050-23","article-title":"Pan-antiviral effects of a PIKfyve inhibitor on respiratory virus infection in human nasal epithelium and mice","volume":"68","author":"Baker","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.bioorg.2026.110337_bb0045","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.cell.2023.01.005","article-title":"PIKFYVE inhibition mitigates disease in models of diverse forms of ALS","volume":"186","author":"Hung","year":"2023","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bioorg.2026.110337_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28527","article-title":"Inhibition of PIKFYVE kinase interferes ESCRT pathway to suppress RNA virus replication","volume":"95","author":"Luo","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bioorg.2026.110337_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100636","article-title":"PIKfyve activity is required for lysosomal trafficking of tau aggregates and tau seeding","volume":"296","author":"Soares","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2026.110337_bb0060","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1007\/s12264-023-01113-x","article-title":"PIKFYVE inhibition, a neuronal \u201cemetic\u201d for treating ALS?","volume":"39","author":"Yue","year":"2023","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.bioorg.2026.110337_bb0065","doi-asserted-by":"crossref","unstructured":"Campos, C. B. de; Zhu, Y. X.; Sepetov, N.; Romanov, S.; Bruins, L. A.; Shi, C.-X.; Stein, C. K.; Petit, J. L.; Polito, A. N.; Sharik, M. E.; Meermeier, E. W.; Ahmann, G. J.; Armenta, I. D. L.; Kruse, J.; Bergsagel, P. L.; Chesi, M.; Meurice, N.; Braggio, E.; Stewart, A. K. Identification of PIKfyve kinase as a target in multiple myeloma. Haematologica 2020, 105 (6), 1641\u20131649. Doi: https:\/\/doi.org\/10.3324\/haematol.2019.222729.","DOI":"10.3324\/haematol.2019.222729"},{"issue":"9","key":"10.1016\/j.bioorg.2026.110337_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/ph18091341","article-title":"Structure\u2013activity relationship study of 3-alkynyl-6-aryl-isothiazolo[4,3-b]pyridines as dual inhibitors of the lipid kinases PIKfyve and PIP4K2C","volume":"18","author":"Kalebic","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110337_bb0075","doi-asserted-by":"crossref","first-page":"6397","DOI":"10.1038\/s41467-025-61759-1","article-title":"PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2","volume":"16","author":"Karim","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.110337_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2026.1777981","article-title":"Synthesis, structure\u2013activity relationships, and SARS-CoV-2 antiviral activity of 3,5-disubstituted isothiazolo[4,3-b]pyridines as PIKfyve inhibitors","volume":"14","author":"Gao","year":"2026","journal-title":"Front. Chem."},{"issue":"36","key":"10.1016\/j.bioorg.2026.110337_bb0085","doi-asserted-by":"crossref","first-page":"7373","DOI":"10.1039\/D4OB00908H","article-title":"Synthesis and evaluation of Isothiazolo[4,5-b]pyridines as cyclin G-associated kinase (GAK) inhibitors","volume":"22","author":"Ivanova","year":"2024","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bioorg.2026.110337_bb0090","author":"Kc"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110337_bb0095","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0040-4039(01)02192-X","article-title":"An efficient method for the N-debenzylation of aromatic heterocycles","volume":"43","author":"Haddach","year":"2002","journal-title":"Tetrahedron Lett."},{"issue":"34","key":"10.1016\/j.bioorg.2026.110337_bb0100","doi-asserted-by":"crossref","first-page":"20803","DOI":"10.1073\/pnas.2007837117","article-title":"Inhibition of PIKfyve kinase prevents infection by Zaire ebolavirus and SARS-CoV-2","volume":"117","author":"Kang","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110337_bb0105","doi-asserted-by":"crossref","first-page":"jcs262236","DOI":"10.1242\/jcs.262236","article-title":"PIKFYVE inhibition induces endosome- and lysosome-derived vacuole enlargement via ammonium accumulation","volume":"138","author":"Uwada","year":"2025","journal-title":"J. Cell Sci."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110337_bb0110","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1600-0854.2009.00915.x","article-title":"PIKfyve regulation of endosome-linked pathways","volume":"10","author":"de Lartigue","year":"2009","journal-title":"Traffic"},{"issue":"8","key":"10.1016\/j.bioorg.2026.110337_bb0115","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"issue":"20","key":"10.1016\/j.bioorg.2026.110337_bb0120","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","article-title":"AmberTools","volume":"63","author":"Case","year":"2023","journal-title":"J. Chem. Inf. Model."},{"issue":"7","key":"10.1016\/j.bioorg.2026.110337_bb0125","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02209-20","article-title":"Generation and characterization of recombinant SARS-CoV-2 expressing reporter genes","volume":"95","author":"Chiem","year":"2021","journal-title":"J. Virol."},{"issue":"19","key":"10.1016\/j.bioorg.2026.110337_bb0130","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169510","article-title":"Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects","volume":"133","author":"Saul","year":"2023","journal-title":"J. Clin. Invest."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826008734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:13:15Z","timestamp":1791407595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826008734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":26,"alternative-id":["S0045206826008734"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110337","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of 3,5-disubstituted isothiazolo[4,5-b]pyridines, pyrazolo[4,3-b]pyridines and isothiazolo[3,4-b]pyrazines as inhibitors of PIKfyve","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110337"}}